Similar results were also observed in other hormone-independent cancers, such as gliomas 21, gastric 22, and colorectal carcinomas 24, in which up-regulated expression of AIB1 was found and correlated with an advanced clinical stage and/or poor prognosis. Here, NCOA3 is linked to colorectal carcinoma.